What happens to narcotic products that do not meet the definitions provided in the CDSA?

Narcotic products that do not meet the definitions provided in the Controlled Drugs and Substances Act (CDSA) are still classified as narcotic drugs but may not fall within the criteria of a controlled substance. The CDSA provides a specific legal framework for what constitutes narcotics, and if a product does not meet those definitions, it may not be subject to the same regulatory controls. However, it retains its classification as a narcotic drug based on its pharmacological properties or potential for abuse.

This classification is important because it ensures that substances which contribute to the definition of a narcotic - even if not strictly controlled under CDSA - still receive a level of scrutiny to monitor their distribution and usage, thereby ensuring public safety and regulatory compliance.

The other options imply that such products would either be treated as entirely separate categories of drugs (like over-the-counter medications) or be exempt from any regulation, which does not align with the overarching goal of the CDSA to manage and control narcotic liabilities responsibly. Thus, being classified as narcotic drugs, while not under the strict definitions of the CDSA, helps maintain awareness and governance over these substances.